U.S. Markets closed

MIT gene-therapy spinout raises $6M, enters competitive mRNA field

Allison DeAngelis
MIT gene-therapy spinout raises $6M, enters competitive mRNA field

Strand Therapeutics hopes to create treatments using messenger RNA or mRNA, which gives instructions to the body’s cells to create proteins. But the young gene-therapy startup thinks it has created a better method than such players as Moderna Inc. and Translate Bio.